Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
As of close of business last night, Autolus Therapeutics plc ADR’s stock clocked out at $1.95, down -2.50% from its previous closing price of $2.00. In other words, the price has decreased by -$2.50 from its previous closing price. On the day, 0.74 million shares were traded.
Ratios:
To gain a deeper understanding of AUTL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.64 and its Current Ratio is at 13.64. In the meantime, Its Debt-to-Equity ratio is 0.63 whereas as Long-Term Debt/Eq ratio is at 0.62.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on November 18, 2024, Upgraded its rating to Buy and sets its target price to $7.60 from $7 previously.
On November 15, 2024, Redburn Atlantic Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $13.
On November 09, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $10.Deutsche Bank initiated its Buy rating on November 09, 2023, with a $10 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 16 ’24 when Martin Pule bought 698,741 shares for $4.23 per share.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 51.43 while its Price-to-Book (P/B) ratio in mrq is 1.09.
Stock Price History:
Over the past 52 weeks, AUTL has reached a high of $6.93, while it has fallen to a 52-week low of $1.87. The 50-Day Moving Average of the stock is -15.27%, while the 200-Day Moving Average is calculated to be -44.38%.
Shares Statistics:
A total of 266.12M shares are outstanding, with a floating share count of 240.31M. Insiders hold about 9.70% of the company’s shares, while institutions hold 53.78% stake in the company.
